- Home
- CTNM vs YSXT Comparison
CTNM vs YSXT Comparison
Compare CTNM & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- YSXT
- Stock Information
- Founded
- CTNM 2009
- YSXT 2011
- Country
- CTNM United States
- YSXT China
- Employees
- CTNM N/A
- YSXT N/A
- Industry
- CTNM
- YSXT Automotive Aftermarket
- Sector
- CTNM
- YSXT Consumer Discretionary
- Exchange
- CTNM Nasdaq
- YSXT Nasdaq
- Market Cap
- CTNM 122.9M
- YSXT 110.4M
- IPO Year
- CTNM 2024
- YSXT 2024
- Fundamental
- Price
- CTNM $4.76
- YSXT $5.38
- Analyst Decision
- CTNM Strong Buy
- YSXT
- Analyst Count
- CTNM 4
- YSXT 0
- Target Price
- CTNM $22.50
- YSXT N/A
- AVG Volume (30 Days)
- CTNM 119.1K
- YSXT 149.3K
- Earning Date
- CTNM 08-12-2025
- YSXT 08-15-2025
- Dividend Yield
- CTNM N/A
- YSXT N/A
- EPS Growth
- CTNM N/A
- YSXT N/A
- EPS
- CTNM N/A
- YSXT 0.18
- Revenue
- CTNM N/A
- YSXT $66,143,276.00
- Revenue This Year
- CTNM N/A
- YSXT N/A
- Revenue Next Year
- CTNM N/A
- YSXT N/A
- P/E Ratio
- CTNM N/A
- YSXT $29.16
- Revenue Growth
- CTNM N/A
- YSXT 21.23
- 52 Week Low
- CTNM $3.35
- YSXT $2.06
- 52 Week High
- CTNM $22.00
- YSXT $9.96
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- YSXT N/A
- Support Level
- CTNM N/A
- YSXT N/A
- Resistance Level
- CTNM N/A
- YSXT N/A
- Average True Range (ATR)
- CTNM 0.00
- YSXT 0.00
- MACD
- CTNM 0.00
- YSXT 0.00
- Stochastic Oscillator
- CTNM 0.00
- YSXT 0.00
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.